325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW, CA
Enters into Agreement to Be Acquired for $1.247 in Cash per Share Plus a Contingent Value Right
News, Material Contracts
Material disclosure
Amended material disclosure
Provides Strategic Update on Autoimmunity Pipeline Programs
Earnings Release
Announces Strategic Pivot to Focus Exclusively on Autoimmunity
Q2
Q1
Amended Annual Report
FY 2024
Q3
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS